Business·Industry

[Exclusive] China's CXMT Shakes Off Its "Domestic-Market-Only" Stigma… 64% of Revenue Generated Overseas

Revenue from Outside Mainland China Rises from 36.9% to 63.8% in One Year Amount Rises from 5.6 Billion to 95.8 Billion Yuan… A 17-Fold Surge Xiaomi, Oppo, and Others Enter the Market Through Finished Product Distribution Channels DRAM Market Share Rises from 4% to 7%… New Variables for Samsung and SK

JAEMIN SONG
2026-08-31 23:50:03
[Edaily Reporter JAEMIN SONG ] The revenue base of China’s largest DRAM manufacturer, Changxin Memory Technology (CXMT), is rapidly shifting outside of China. The share of revenue generated outside mainland China has jumped from the 30% range to the 60% range in just one year. Analysts say that CXMT, which grew by leveraging the domestic market, is now expanding its overseas presence through the global distribution networks of Chinese finished-product manufacturers, emerging as a new variable in the general-purpose and mobile DRAM markets previously dominated by Korean memory manufacturers.

CXMT is promoting its DRAM products, including DDR5 and LPDDR, at the China International Semiconductor Expo held in Beijing in November 2025. (Photo: CXMT)

According to CXMT’s semi-annual report released on the 31st, out of 150 billion yuan (approximately 30 trillion won) in revenue for the first half of this year, revenue from outside mainland China totaled 95.8 billion yuan, accounting for 63.8 percent. This is 1.8 times the 54.2 billion yuan in mainland revenue. The share of revenue from outside the mainland, which stood at 36.9% in the first half of last year, rose by 26.9 percentage points in just one year, reversing the regional revenue composition. In terms of absolute value, it surged approximately 17-fold from 5.6 billion yuan.

Revenue from outside the mainland includes transactions in Hong Kong, a hub for semiconductor trade and dollar settlements. Since CXMT did not disclose separate revenue figures for Hong Kong and other regions in the first half of this year, there may be a discrepancy with actual overseas final demand. However, given that the share of revenue from outside the mainland has nearly doubled under the same criteria, it can be interpreted that the company is shaking off its reputation as a “domestic-market-focused” player in offshore markets.

CXMT stated that its LPDDR4X has entered the supply chains of IT companies such as Xiaomi, Oppo, Vivo, Transsion, and Lenovo, and has entered overseas markets through these companies’ device distribution channels. CXMT’s overseas assets still account for only 0.15% of its total assets. This suggests that the company is relying on its factories in China and its customers’ sales networks rather than separate overseas production bases.

According to market research firm Counterpoint Research, CXMT’s global DRAM revenue market share rose from 4% in the second quarter of last year to 7% in the second quarter of this year. The gap with SamsungElectronics (39%) and SK hynix (26%) remains significant. However, if CXMT expands its global supply base—particularly in general-purpose DDR DRAM and mobile LPDDR DRAM—it could pose a challenge to “K-Memory” in the medium to long term.

Economy

Corporation

IT·Science

Economy

[Exclusive] China's CXMT Gains Global Foothold with Huawei and Xiaomi… Will It Shake Up K-Memory?

The fact that memory products from China’s largest DRAM manufacturer, Changxin Memory Technology (CXMT), have entered the supply chains of domestic smartphone manufacturers and are now flooding overse…
2026-08-31 23:50:03

Corporation

Samyang Corporation Exempt from 'Starch Price-Fixing Fine'... Daesang Must Pay 234.1 Billion Won

Samyang Corporation has been fully exempted from the 210.3 billion won in fines related to the starch price-fixing cartel. In contrast, Daesang received a notice from the Fair Trade Commission requiri…
2026-08-31 18:14:38

IT·Science

National Growth Fund Provides 20 Billion Won to KYONGBO PHARMACEUTICAL CO., LTD.… Accelerating Entry into the ADC CDMO Market

KYONGBO PHARMACEUTICAL CO., LTD. CI (Photo: KYONGBO PHARMACEUTICAL CO., LTD.) The National Growth Fund is providing a 20 billion won low-interest loan to KYONGBO PHARMACEUTICAL CO., LTD.(214390), …
2026-08-31 18:12:02